Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Hilmi, Tozkir"'
Publikováno v:
Clinical Dysmorphology. 32:65-69
Autor:
Nuray CAN, Ebru TAŞTEKIN, Tülin DENIZ YALTA, Necdet SÜT, Selma KORKMAZ, Ufuk USTA, Fulya ÖZ PUYAN, Ezgi GENÇ, Mert CEZIK, Busem BINBOĞA TUTUĞ, Osman KÖSTEK, Hilmi TOZKIR
Publikováno v:
Türk Patoloji Dergisi, Vol 34, Iss 2, Pp 134-142 (2018)
Objective: BRAF is the most common mutation in melanoma. The most common subtype is BRAF V600E, followed by V600K. Initially, the authors aimed to investigate whether clinicopathological features of melanoma are associated with BRAF mutations. We the
Externí odkaz:
https://doaj.org/article/c7410c8419314fd996c3fa6d2a221ba6
Publikováno v:
Biochemical and biophysical research communications. 619
TP73 antisense RNA 1 (TP73-AS1) is an oncogenic long non-coding RNA that is activated in several types of cancers. It has been shown that the activity of TP73-AS1 is controlled by several miRNAs, but post-transcriptional mechanisms that regulate TP73
Autor:
Hakan Gurkan, Sinem Yalcintepe, Damla Eker, Hilmi Tozkir, Irfan Cicin, Emine Ikbal Atli, Huseyin Ahmet Tezel, Engin Atli, Selma Demir
Publikováno v:
Tumori Journal. 106:510-517
Background: Recent advances in next-generation sequencing (NGS) technology have enabled multigene testing and changed the diagnostic approach to hereditary gastrointestinal cancer/polyposis syndromes. The aim of this study was to analyze different ca
Publikováno v:
Molecular biology reports. 49(7)
Prostate cancer is a malignant disease that severely affects the health and comfort of the male population. The long non-coding RNA TP73-AS1 has been shown to be involved in the malignant transformation of various human cancers. However, whether TP73
Autor:
Emine Ikbal Atli, Necdet Sut, Drenushe Zhuri, Hakan Gurkan, Işık Görker, Cisem Mail, Sinem Yalcintepe, Damla Eker, Hilmi Tozkir, Yasemiin Ozen, Hazal Sezginer Guler, Selma Demir, Engin Atli
Publikováno v:
Archives of Neuropsychiatry.
Introduction Autism spectrum disorder is a genetically and phenotypically heterogeneous group. Genetic studies carried out to date have suggested that both common and rare genetic variants play a role in the etiology of this disorder. In our study, w
Autor:
Selma, Demir, Hilmi, Tozkir, Hakan, Gurkan, E Ikbal, Atli, Sinem, Yalcintepe, Engin, Atli, Y Atakan, Sezer, Damla, Eker, Nermin, Tuncbilek, Ebru, Tastekin, Yasemin, Ozen, Irfan, Cicin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(3)
Pathogenic/likely pathogenic (P/LP) germline variations in BRCA1 and BRCA2 genes are responsible for the majority of hereditary breast and ovarian cancers. This study presents the BRCA1/BRCA2 sequencing and deletion duplication analyses results of of
Autor:
Mehmet Celik, Sibel Guldiken, Semra Ayturk, Buket Yilmaz Bulbul, Ahmet Kucukarda, Nuray Can, Ebru Tastekin, Atakan Sezer, Necdet Sut, Armagan Tugrul, Hakan Gurkan, Hilmi Tozkir, Bora Demirkan
Publikováno v:
Journal of Elementology.
Publikováno v:
Balkan Journal of Medical Genetics, Vol 21, Iss 2, Pp 69-72 (2018)
Balkan Journal of Medical Genetics : BJMG
Balkan Journal of Medical Genetics : BJMG
The balanced non-Robertsonian translocation (ROB) associated with acrocentric chromosomes is an unusual phenomenon. We report the case of rare non-ROB involving chromosomes 15 and 22 with cytogenetic and molecular cytogenetic findings of 46,XY,t(15;2
Autor:
Ezgi Genc, Nuray Can, Necdet Sut, Hilmi Tozkir, Mert Cezik, Ebru Tastekin, Fulya Oz Puyan, Busem Binboğa Tutuğ, Osman Kostek, Tulin Yalta, Selma Korkmaz, Ufuk Usta
Publikováno v:
Türk Patoloji Dergisi, Vol 34, Iss 2, Pp 158-164 (2018)
Objective BRAF is the most common mutation in melanoma. The most common subtype is BRAF V600E, followed by V600K. Initially, the authors aimed to investigate whether clinicopathological features of melanoma are associated with BRAF mutations. We then